×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BMRA – biomerica, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BMRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/26
08:34 am
bmra
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy [Yahoo! Finance]
Medium
Report
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy [Yahoo! Finance]
2/26
08:19 am
bmra
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
Low
Report
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
2/18
08:19 am
bmra
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
Medium
Report
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
1/14
05:17 pm
bmra
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
Low
Report
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
12/23
09:02 am
bmra
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test [Yahoo! Finance]
Medium
Report
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test [Yahoo! Finance]
12/23
08:19 am
bmra
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
Medium
Report
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
12/11
09:13 am
bmra
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio [Yahoo! Finance]
Low
Report
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio [Yahoo! Finance]
12/11
08:08 am
bmra
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
Medium
Report
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/28
05:40 pm
bmra
Form 4 BIOMERICA INC For: Dec 12 Filed by: Chin Eric
Low
Report
Form 4 BIOMERICA INC For: Dec 12 Filed by: Chin Eric
1/14
05:16 pm
bmra
Form 10-Q BIOMERICA INC For: Nov 30
Low
Report
Form 10-Q BIOMERICA INC For: Nov 30
12/31
05:10 pm
bmra
Form 4 BIOMERICA INC For: Dec 12 Filed by: BARBIERI ALLEN
Low
Report
Form 4 BIOMERICA INC For: Dec 12 Filed by: BARBIERI ALLEN
12/31
05:10 pm
bmra
Form 4 BIOMERICA INC For: Dec 12 Filed by: Irani Zackary S.
Low
Report
Form 4 BIOMERICA INC For: Dec 12 Filed by: Irani Zackary S.
12/31
05:10 pm
bmra
Form 4 BIOMERICA INC For: Dec 12 Filed by: MOATAZEDI DAVID
Low
Report
Form 4 BIOMERICA INC For: Dec 12 Filed by: MOATAZEDI DAVID
12/31
05:10 pm
bmra
Form 4 BIOMERICA INC For: Dec 12 Filed by: Gary M. Huff
Low
Report
Form 4 BIOMERICA INC For: Dec 12 Filed by: Gary M. Huff
12/31
05:10 pm
bmra
Form 4 BIOMERICA INC For: Dec 12 Filed by: Lu Gary
Low
Report
Form 4 BIOMERICA INC For: Dec 12 Filed by: Lu Gary
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
334.6%
3/22 Labs race to produce tests that show where COVID-19 has already been [Toronto Globe and Mail (Ontario, Canada)] 35.8%
10/15 Q1/2020 8/31/2019 EPS -0.050 ZacksConsensus -0.060 ActVsEst 0.010 - Beat 9.7%
6/5 Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million. 8.0%
3/4 Form SC 13D BIOMERICA INC Filed by: Palm Management (US) LLC 6.1%
9/11 Biomerica, Inc. (NASDAQ: BMRA) was given a new $6.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock. 6.1%
12/30 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 5.4%
4/3 Form 4 BIOMERICA INC For: Apr 01 Filed by: BARBIERI ALLEN 3.0%
1/9 Form 8-K BIOMERICA INC For: Jan 09 2.8%
12/23 Form 4 BIOMERICA INC For: Dec 19 Filed by: BARBIERI ALLEN 2.7%
3/22 Labs race to produce tests that show where COVID-19 has already been [Toronto Globe and Mail (Ontario, Canada)] 35.8%
10/15 Q1/2020 8/31/2019 EPS -0.050 ZacksConsensus -0.060 ActVsEst 0.010 - Beat 9.7%
6/5 Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million. 8.0%
3/4 Form SC 13D BIOMERICA INC Filed by: Palm Management (US) LLC 6.1%
9/11 Biomerica, Inc. (NASDAQ: BMRA) was given a new $6.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock. 6.1%
12/30 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 5.4%
4/3 Form 4 BIOMERICA INC For: Apr 01 Filed by: BARBIERI ALLEN 3.0%
1/9 Form 8-K BIOMERICA INC For: Jan 09 2.8%
12/23 Form 4 BIOMERICA INC For: Dec 19 Filed by: BARBIERI ALLEN 2.7%
TOP News Decliners
3/20
Form 424B5 BIOMERICA INC
-41.5%
6/5 Form 8-K BIOMERICA INC For: May 31 -8.8%
4/2 A coronavirus immunity test is essential for the U.S. But will it work? [Los Angeles Times (CA)] -7.6%
3/25 U.S. companies, labs rush to produce blood test for coronavirus immunity [Reuters] -7.3%
3/2 Form 4 BIOMERICA INC For: Feb 28 Filed by: Irani Zackary S. -5.8%
1/14 Form 10-Q BIOMERICA INC For: Nov 30 -5.4%
11/7 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -4.5%
4/14 Form 10-Q BIOMERICA INC For: Feb 29 -3.8%
4/21 Form 4 BIOMERICA INC For: Apr 17 Filed by: Sirgo Mark A -3.0%
4/6 Form 8-K BIOMERICA INC For: Apr 01 -1.3%
6/5 Form 8-K BIOMERICA INC For: May 31 -8.8%
4/2 A coronavirus immunity test is essential for the U.S. But will it work? [Los Angeles Times (CA)] -7.6%
3/25 U.S. companies, labs rush to produce blood test for coronavirus immunity [Reuters] -7.3%
3/2 Form 4 BIOMERICA INC For: Feb 28 Filed by: Irani Zackary S. -5.8%
1/14 Form 10-Q BIOMERICA INC For: Nov 30 -5.4%
11/7 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -4.5%
4/14 Form 10-Q BIOMERICA INC For: Feb 29 -3.8%
4/21 Form 4 BIOMERICA INC For: Apr 17 Filed by: Sirgo Mark A -3.0%
4/6 Form 8-K BIOMERICA INC For: Apr 01 -1.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: